Publication | Closed Access

Overexpression of c-erbB-2 is related to a higher expression of vascular endothelial growth factor (VEGF) and constitutes an independent prognostic factor in primary node-positive breast cancer after adjuvant systemic treatment

Breast OncologyHigher ExpressionMedicinePathologyBreast CancerIndependent Prognostic FactorAdjuvant Systemic TreatmentOncologyCell BiologyTumor MicroenvironmentTumor BiologyCancer Growth